- Home
- GAIA vs KZIA Comparison
GAIA vs KZIA Comparison
Compare GAIA & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GAIA | KZIA |
|---|---|---|
| Founded | 1988 | 1994 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 84.9M | 93.2M |
| IPO Year | 1999 | 2002 |
Fundamental Metrics
Financial Performance| Metric | GAIA | KZIA |
|---|---|---|
| Price | $2.88 | $7.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $9.00 | ★ $17.67 |
| AVG Volume (30 Days) | 64.3K | ★ 183.8K |
| Earning Date | 03-02-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,500,000.00 | N/A |
| Revenue This Year | $13.15 | N/A |
| Revenue Next Year | $16.92 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.50 | N/A |
| 52 Week Low | $2.93 | $0.64 |
| 52 Week High | $6.39 | $17.40 |
Technical Indicators
Market Signals| Indicator | GAIA | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 37.55 | 53.04 |
| Support Level | N/A | $7.54 |
| Resistance Level | $3.46 | $8.17 |
| Average True Range (ATR) | 0.22 | 1.08 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 17.74 | 27.64 |
Price Performance
Historical ComparisonAbout GAIA Gaia Inc.
Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.